WRAPUP 1-Bristol-Myers set to lead earnings parade in 2016, beyond

Jan 28 (Reuters) - Bristol-Myers Squibb Co on Thursday positioned itself as a potential earnings pacesetter in 2016, with a forecast of up to 19 percent growth that eclipses profit gains expected by most other large drugmakers.